Colorectal
Armaan Ahmed
Undergraduate Student
Johns Hopkins University
Larchmont, New York, United States
Armaan Ahmed
Undergraduate Student
Johns Hopkins University
Larchmont, New York, United States
Armaan Ahmed
Undergraduate Student
Johns Hopkins University
Larchmont, New York, United States
Jennifer Whittington, MD, PhD, FACS, FSSO
Attending Surgeon and Assistant Professor of Surgery
Elmhurst Hospital, NYC Health + Hospitals, New York, NY, USA, Department of Surgery, Icahn School of Medicine, New York, NY, USA, United States
Zahra Shafaee, MD, MBA, FSSO, FACS (she/her/hers)
Attending Surgeon and Assistant Professor of Surgery
Elmhurst Hospital, NYC Health + Hospitals, New York, NY, USA, Department of Surgery, Icahn School of Medicine, New York, NY, USA
Larchmont, New York, United States
Appendiceal neoplasms (AN) are rare tumors with a broad spectrum of referral and treatment patterns. Here, we study patterns of presentation and management of AN in a large municipal health care delivery system.
Methods:
We identified 92 patients with AN between 01/01/2017 to 07/01/2023 in a retrospective case review. Demographic, diagnostic, and primary surgery variables were captured for all cases, and, for the non-neuroendocrine cases, genetic, stage, and further treatment variables were noted. Statistical analyses were performed in Python.
Results:
There were 38 (41.3%) mucinous neoplasms, 24 (26.1%) adenocarcinomas, 23 (25.0%) neuroendocrine, and 7 (7.6%) ex-goblet cell adenocarcinomas. 16 cases of pseudomyxoma peritonei were identified. The median age at diagnosis was 55 (IQR: 45-65). 49% were Hispanic, and African Americans were the largest racial block (28%). 50% of cases presented as appendicitis. In this group, appendectomy and a second surgical intervention was significantly more commonly performed (p< 0.001 and p=0.044, respectively). Other surgical interventions included colon resections and cytoreduction ± Hyperthermic intraperitoneal chemotherapy. Among the patients with mucinous neoplasm or adenocarcinoma, 35 (50.7%) had multidisciplinary tumor board discussion (15 mucinous neoplasm and 20 adenocarcinomas). The median follow-up period was 22.0 months (95% CI: 11.5-30.7 months). Surveillance modalities included CT (75%), CEA (74%), and colonoscopy (35%). 85% remained within HHC during treatment. 16 patients were planned to have chemotherapy, including 9 pseudomyxoma peritonei cases. 5 patients did not follow through, and the other cases had a median of 10 cycles. The following adjuvant chemotherapy regimens were employed: 50% FOLFOX, 20% FOLFIRI, 20% XELODA, and 10% CapeOX and FOLFIRI. There were 2 cancer-related deaths (pseudomyxomas). Excluding pseudomyxomas, none had evidence of disease at the last follow-up.
Conclusions:
Minorities and immigrants constitute the majority of the population in this institutional retrospective case review. 50% of AN presented as appendicitis emphasizing the need for a robust system to identify these cases. Despite challenges encountered in providing long-term oncological care, vigorous follow-up has been provided for this underserved population.